We canât show the full text here under this license. Use the link below to read it at the source.
AI in Medical Questionnaires: Scoping Review
Jun 23, 2025Journal of medical Internet research
Use of AI in Medical Questionnaires: Overview
AI simplified
Abstract
Of 49,091 publications, only 14 (0.03%) studies met the inclusion criteria for exploring AI applications in medical questionnaires.
- AI technologies demonstrated 92.18% accuracy in distinguishing myalgic encephalomyelitis or chronic fatigue syndrome from long COVID-19.
- Natural language processing tools like ChatGPT were used to create culturally competent scales for questionnaire development.
- One study achieved an area under the curve of 0.790 for predicting the risk of cataract surgery.
- Only 21% (3/14) of the studies progressed to clinical validation, while 79% (11/14) remained exploratory.
- Seventy-one percent (10/14) of the studies were rated as having moderate methodological quality, with common limitations such as lack of control groups.
AI simplified
UNLABELLED: This systematic review aimed to explore the current applications, potential benefits, and issues of artificial intelligence (AI) in medical questionnaires, focusing on its role in 3 main functions: assessment, development, and prediction. The global mental health burden remains severe. The World Health Organization reports that >1 billion people worldwide experience mental disorders, with the prevalence of depression and anxiety among children and adolescents at 2.6% and 6.5%, respectively. However, commonly used clinical questionnaires such as the Hamilton Depression Rating Scale and the Beck Depression Inventory suffer from several problems, including the high degree of overlap of symptoms of depression with those of other psychiatric disorders and a lack of professional supervision during administration of the questionnaires, which often lead to inaccurate diagnoses. In the wake of the COVID-19 pandemic, the health care system is facing the dual challenges of a surge in patient numbers and the complexity of mental health issues. AI technology has now been shown to have great promise in improving diagnostic accuracy, assisting clinical decision-making, and simplifying questionnaire development and data analysis. To systematically assess the value of AI in medical questionnaires, this study searched 5 databases (PubMed, Embase, Cochrane Library, Web of Science, and China National Knowledge Infrastructure) for the period from database inception to September 2024. Of 49,091 publications, a total of 14 (0.03%) studies met the inclusion criteria. AI technologies showed significant advantages in assessment, such as distinguishing myalgic encephalomyelitis or chronic fatigue syndrome from long COVID-19 with 92.18% accuracy. In questionnaire development, natural language processing using generative models such as ChatGPT was used to construct culturally competent scales. In terms of disease prediction, one study had an area under the curve of 0.790 for cataract surgery risk prediction. Overall, 24 AI technologies were identified, covering traditional algorithms such as random forest, support vector machine, and k-nearest neighbor, as well as deep learning models such as convolutional neural networks, Bidirectional Encoder Representations From Transformers, and ChatGPT. Despite the positive findings, only 21% (3/14) of the studies had entered the clinical validation phase, whereas the remaining 79% (11/14) were still in the exploratory phase of research. Most of the studies (10/14, 71%) were rated as being of moderate methodological quality, with major limitations including lack of a control group, incomplete follow-up data, and inadequate validation systems. In summary, the integrated application of AI in medical questionnaires has significant potential to improve diagnostic efficiency, accelerate scale development, and promote early intervention. Future research should pay more attention to model interpretability, system compatibility, validation standardization, and ethical governance to effectively address key challenges such as data privacy, clinical integration, and transparency.
BACKGROUND: The World Health Organization reports that >1 billion people worldwide experience mental disorders, with the prevalence of depression and anxiety among children and adolescents at 2.6% and 6.5%, respectively. However, commonly used clinical questionnaires such as the Hamilton Depression Rating Scale and the Beck Depression Inventory suffer from several problems, including the high degree of overlap of symptoms of depression with those of other psychiatric disorders and a lack of professional supervision during administration of the questionnaires, which often lead to inaccurate diagnoses. In the wake of the COVID-19 pandemic, the health care system is facing the dual challenges of a surge in patient numbers and the complexity of mental health issues. Artificial Intelligence (AI) technology has now been shown to have great promise in improving diagnostic accuracy, assisting clinical decision-making, and simplifying questionnaire development and data analysis.
OBJECTIVE: This review aimed to explore the current applications, potential benefits, and issues of AI in medical questionnaires, focusing on its role in 3 main functions: assessment, development, and prediction. The global mental health burden remains severe.
METHODS: The review included peer-reviewed studies that applied AI technologies to medical, psychological, or physiological questionnaires and reported measurable outcomes; nonâpeer-reviewed, non-English/Chinese, ethically noncompliant, or AI-unrelated studies were excluded. Five databases (PubMed, Embase, Cochrane Library, Web of Science, and CNKI) were searched from inception through September 2024. Three independent reviewers conducted data extraction, quality appraisal using the Joanna Briggs Institute tools, and narrative synthesis of AI applications across questionnaire assessment, development, and prediction tasks.
RESULTS: Of 49,091 publications, a total of 14 (0.03%) studies met the inclusion criteria. AI technologies showed advantages in assessment, such as distinguishing myalgic encephalomyelitis or chronic fatigue syndrome from long COVID-19 with 92.18% accuracy. In questionnaire development, natural language processing using generative models such as ChatGPT was used to construct culturally competent scales. In terms of disease prediction, one study had an area under the curve of 0.790 for cataract surgery risk prediction. Overall, 24 AI technologies were identified, covering traditional algorithms such as random forest, support vector machine, and k-nearest neighbor, as well as deep learning models such as convolutional neural networks, Bidirectional Encoder Representations From Transformers, and ChatGPT. Despite the positive findings, only 21% (3/14) of the studies had entered the clinical validation phase, whereas the remaining 79% (11/14) were still in the exploratory phase of research. Most of the studies (10/14, 71%) were rated as being of moderate methodological quality, with major limitations including lack of a control group, incomplete follow-up data, and inadequate validation systems.
CONCLUSIONS: In summary, the integrated application of AI in medical questionnaires has significant potential to improve diagnostic efficiency, accelerate scale development, and promote early intervention. Future research should pay more attention to model interpretability, system compatibility, validation standardization, and ethical governance to effectively address key challenges such as data privacy, clinical integration, and transparency.
Related papers
Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 21 papers
systematic review
Aug '25
Using AI and Virtual Reality Technologies for Mental Health in the Metaverse
top 5% journal
cited by 10 papers
journal article
Sep '25
Generative Artificial Intelligence in Pregnancy Care for Older Mothers: Recent Advances and Clinical Uses
top 30% journal
retracted publication
Aug '25
Artificial Intelligence in Thickened Heart Muscle Disease: Progress, Challenges, and Future Steps for Personalized Risk Prediction and Care
journal article
Mar '25
How Artificial Intelligence is Being Used in Medical Care: Current Patterns, Challenges, and Possible Future Paths
top 50% journal
cited by 58 papers
systematic review
Dec '20
Quick reviews of health research problems in regional, rural, and remote Australia
top 10% journal
cited by 25 papers
journal article
Oct '20
The Future Directions of Cochrane Neonatal Research
top 30% journal
cited by 16 papers
research support, non-u.s. gov't
Aug '25
How Artificial Intelligence May Affect Nursing Work and Patient Results
top 20% journal
cited by 8 papers
systematic review
Nov '24
Using Artificial Intelligence to Detect Breast Cancer and Evaluate Its Health Impact: A Broad Review
top 10% journal
cited by 29 papers
journal article
Apr '25
Using Artificial Intelligence to Help Diagnose Digestive Tract Cancers: Opportunities and Challenges in Endoscopy and Tissue Analysis
top 5% journal
cited by 19 papers
systematic review